Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction
Ramos, F, Thépot, S, Pleyer, L, Maurillo, L, Itzykson, R, Bargay, J, Stauder, R, Venditti, A, Seegers, V, Martínez-Robles, V, Burgstaller, S, Récher, C, Debén, G, Gaidano, G, Gardin, C, Musto, P, Greil, R, Sánchez-Guijo, F, Fenaux, P
Published in Leukemia research (01.03.2015)
Published in Leukemia research (01.03.2015)
Get full text
Journal Article
205 A SINGLE CENTER REPORT OF THERAPEUTIC STRATEGIES IN PATIENTS WITH ATYPICAL CML (ACML) AND UNCLASSIFIED MDS/MPN (MDS/MPN-U)
Braun, T, Debache, A, Roudot, H, Lusina, D, Thépot, S, Eclache, V, Martin, A, Soret, J, Bréchignac, S, Kelaidi, C, Adès, L, Fenaux, P, Gardin, C
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
P-283 Efficacy of salvage with decitabine (DAC) for high-risk (HR)-MDS and advanced CMML after azacitidine (AZA) treatment failure
Braun, T, Cherait, A, Rigal, M, Bréchignac, S, Thépot, S, Gardin, C, Adès, L, Fenaux, P
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia
Tailler, M, Senovilla, L, Lainey, E, Thépot, S, Métivier, D, Sébert, M, Baud, V, Billot, K, Fenaux, P, Galluzzi, L, Boehrer, S, Kroemer, G, Kepp, O
Published in Oncogene (26.07.2012)
Published in Oncogene (26.07.2012)
Get full text
Journal Article
Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine
ITZYKSON, R, THEPOT, S, GARDIN, C, ADES, L, FENAUX, P, ECLACHE, V, QUESNEL, B, DREYFUS, F, BEYNE-RAUZY, O, TURLURE, P, VEY, N, RECHER, C, BOEHRER, S
Published in Leukemia (01.07.2011)
Published in Leukemia (01.07.2011)
Get full text
Journal Article
The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation
THEPOT, S, ZHOU, J, SOCIE, G, PERROT, A, ROBIN, M, XHAARD, A, DE LATOUR, R. P, ADES, L, RIBAUD, P, PETROPOULOU, A. D, PORCHER, R
Published in Leukemia (01.11.2010)
Published in Leukemia (01.11.2010)
Get full text
Journal Article
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
Itzykson, R, Thépot, S, Beyne-Rauzy, O, Ame, S, Isnard, F, Dreyfus, F, Salanoubat, C, Taksin, A.L, Chelgoum, Y, Berthon, C, Malfuson, J.V, Legros, L, Vey, N, Turlure, P, Gardin, C, Boehrer, S, Ades, L, Fenaux, P
Published in Leukemia research (01.04.2012)
Published in Leukemia research (01.04.2012)
Get full text
Journal Article
French consensus on myelodysplasic syndrome and chronic myelomonocytic leukemia: diagnostic, classification and treatment 2015 update by the Myelodysplasia French Group
Fenaux, Groupe de travail : P, Ades, L, Fontenay, M, Raynaud, S, Eclache, V, Rose, C, Guerci-Bresler, A, Gyan, E, Robin, M, Prebet, T, Itzykson, R, Cluzeau, T, Natarajan-Amé, S, Stamatoullas, A, Wattel, E, Park, S, Beyne Rauzy, O, Solary, E, Bordessoule, D, Isnard, F, Quesnel, B, Yakoub Agha, I, Toma, A, Thépot, S, Braun, T, Gardin, C, Chèze, S, Delaunay, J, Dimicoli, S, Kosmider, O, Renneville, A, Preudhomme, C, Chermat, F, Vey, N, Dreyfus, F
Published in Hématologie (01.01.2015)
Published in Hématologie (01.01.2015)
Get full text
Journal Article
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
BOEHRER, S, ADES, L, TAILLER, M, OLAUSSEN, K. A, GARDIN, C, ECLACHE, V, DE BOTTON, S, THEPOT, S, FENAUX, P, KROEMER, G, TAJEDDINE, N, HOFMANN, W. K, KRIENER, S, BUG, G, OTTMANN, O. G, RUTHARDT, M, GALLUZZI, L, FOUASSIER, C
Published in Oncogene (04.06.2009)
Published in Oncogene (04.06.2009)
Get full text
Journal Article
Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: MESENCHYMAL STROMAL CELLS OF THE BONE MARROW NICHE CONTRIBUTE TO THE PROINFLAMMATORY PHENOTYPE OF CMML MONOCYTES THROUGH IGFBP2
Marchand, V., Jego, C., Valensi, L., Fenaux, P., Itzykson, R., Willekens, C., Thépot, S., Berthon, C., Braun, T., Etienne, G., Selimoglu-Buet, D., Renneville, A., Elvira-Matelot, E., Porteu, F., Droin, N., Laplane, L., Solary, E.
Published in Leukemia research (01.05.2023)
Published in Leukemia research (01.05.2023)
Get full text
Journal Article
Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: CMML PATIENTS WITH LOW EXPRESSION OF TP53 POINT TO AML TRANSFORMATION
Imanci, A., Laplane, L., Selimoglu-Buet, D., Morabito, M., Francillette, M., Bouchra, B., Wagner-Ballon, O., Thépot, S., Porteu, F., Fenaux, P., Figueroa, M., Itzykson, R., Solary, E., Droin, N.
Published in Leukemia research (01.05.2023)
Published in Leukemia research (01.05.2023)
Get full text
Journal Article
Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: CXCL8 SECRETED BY IMMATURE GRANULOCYTES INHIBITS WILD-TYPE STEM AND PROGENITOR CELL EXPANSION IN CHRONIC MYELOMONOCYTIC LEUKEMIA
Deschamps, P., Gosseye, A., Morabito, M., Imanci, A., Marchand, V., Patnaik, M., Badaoui, B., Braun, T., Berthon, C., Willekens, C., Itzykson, R., Wagner-Ballon, O., Thépot, S., Fenaux, P., Porteu, F., Droin, N., Laplane, L., Solary, E., Selimoglu-Buet, D.
Published in Leukemia research (01.05.2023)
Published in Leukemia research (01.05.2023)
Get full text
Journal Article
Sintra-Rev Clinical Trial: Preliminary Analysis of Efficacy and Safety at Week 12 of Treatment in MDS Del(5Q) and Transfusion Independence
López Cadenas, F, Xicoy, B, Sánchez, J, Fenaux, P, Hernández Rivas, J.Á, Amigo, M.L, Coll, R, Lumbreras, E, Slama, B, Bernal, T, De Paz, R, Platzbecker, U, Giagounidis, A, Nomdedeu, B, Thepot, S, Sanz, G, Arrizabalaga, B, Bargay, J, Del Cañizo Fernández-Roldán, M.C, Díez-Campelo, M
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
Outcome of Lower-Risk Patients with Myelodysplastic Syndromes without 5Q Deletion after Failure of Erythropoiesis Stimulating Agents
Park, S, Hamel, J.F, Toma, A, Kelaidi, C, Thepot, S, Campelo Diez, M, Santini, V, Sekeres, M, Balleari, E, Kaivers, J, Goetze, K, Beyne-Rauzy, O, Stamatoullas, A, Kotsianidis, I, Komrokji, R, Steensma, D, Germing, U, Sanz, G, Dreyfus, F, Fenaux, P
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: LONG-TERM MUTATIONAL DYNAMICS IN DEL(5Q) MDS PATIENTS EARLY TREATED WTIH LENALIDOMIDE (SINTRAREV CLINICAL TRIAL). SAFE AND EFFECITIVE APPROACH REGARDING CLONAL EVOLUTION?
Castelló, S.M. Toribio, López-Cadenas, F., Preudhomme, C., Ramiro, A. Villaverde, Fenwarth, L., Lumbreras, E., Gonzalez, T., Del Rey, M., Xicoy, B., Renneville, A., Sánchez, J., Coll, R., Slama, B., Rivas, J.Á. Hernandez, Thépot, S., Bernal, T., Guerci-Bresler, A., Götze, K., Rivas, J.M. Hernandez, Fenaux, P., Del Cañizo, C., Campelo, M.
Published in Leukemia research (01.05.2023)
Published in Leukemia research (01.05.2023)
Get full text
Journal Article
P-284 Impact of cytogenetics and cytogeneticresponse on outcome in MDS treated with azacitidine (AZA)
Sebert, M, Vidal, V, Eclache, V, Thepot, S, Itzykson, R, Braun, T, Gardin, C, Fenaux, P, Ades, L
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
O-017 A Phase I/II trial of erlotinib (ERLO) in higher-risk MDS after azacitidine (AZA) failure
Thepot, S, Boehrer, S, Prebet, T, Beyne-Rauzy, O, Wattel, E, Delaunay, J, Raffoux, E, Schmidt, A.L, Wickenhauser, S, Dreyfus, F, Fenaux, P, Adès, L
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
Prévalence de l’ostéoporose chez les patients avec syndrome myélodysplasique
Sabty, I. Al, Thépot, S., Legrand, E., Bouvard, B.
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2021)
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2021)
Get full text
Journal Article
O-010 Prognostic factors of response to azacitidine (AZA) in low-risk MDS resistant to erythroid stimulating agents (ESA). The GFM Azaepo 08 study
Gardin, C, Thepot, S, Beyne-Rauzy, O, Benabdelali, R, Prebet, T, Park, S, Stamatoulas, A, Guerci-Bresler, A, Cheze, S, Tertian, G, Choufi, B, Legros, L, Bastie, J.N, Delaunay, J, Chaury, M.P, Wattel, E, Dreyfus, F, Preudhomme, C, Vey, N, Fenaux, P
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article